ATG4B Antibody - BSA Free

FUNCTION: Cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes. ENZYME REGULATION: Inhibited by N-ethylmaleimide. SUBCELLULAR LOCATION: Cytoplasm (Probable). ALTERNATIVE PRODUCTS: 5 named isoforms produced by alternative splicing.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Rat.

We have publications tested in 2 applications: IHC-P, WB.

Showing Publication 1 - 1 of 1.

Publication using NBP2-41307	Applications	Species
Wan DF, Pan SS, Tong YS, Huang Y Exercise Preconditioning Promotes Autophagy to Cooperate for Cardioprotection by Increasing LC3 Lipidation-Associated Proteins Frontiers in physiology 2021-05-05 [PMID: 34025444] (WB, IHC-P, Rat)	WB, IHC-P	Rat

Array NBP2-41307

• ATG4B Antibodies
• ATG4B Lysates
• ATG4B Protein